ARIX BIOSCIENCE PLC
ISIN: GB00BD045071 | LEI: 213800OVT3AHQCXNIX43
Country: United Kingdom
50 Duke Street, W1K 6JL London – United Kingdom
| Line item in (gbp) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Assets | N/A | 257,078,000.00 | 227,847,000.00 |
| Noncurrent Assets | N/A | 121,009,000.00 | 102,847,000.00 |
| Property Plant And Equipment | N/A | 85,000.00 | 57,000.00 |
| Investment Accounted For Using Equity Method | N/A | 120,635,000.00 | 102,694,000.00 |
| Current Assets | N/A | 136,069,000.00 | 125,000,000.00 |
| Cash and cash equivalents | 112,085,000.00 | 134,230,000.00 | 122,782,000.00 |
| Other Current Assets | N/A | 1,839,000.00 | 2,218,000.00 |
| Equity | 328,209,000.00 | 255,357,000.00 | 225,913,000.00 |
| Retained Earnings | N/A | 80,694,000.00 | 51,250,000.00 |
| Other Reserves | N/A | -13,922,000.00 | -13,922,000.00 |
| Liabilities | N/A | 1,721,000.00 | 1,934,000.00 |
| Current Liabilities | N/A | 1,600,000.00 | 1,923,000.00 |
| Trade And Other Current Payables | N/A | 1,600,000.00 | 1,864,000.00 |
| Line item in (gbp) | 01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|
| Revenue | 340,000.00 | 112,000.00 |
| Employee Benefits Expense | -266,000.00 | 0.00 |
| Profit Loss From Operating Activities | -60,137,000.00 | -29,160,000.00 |
| Finance Income | 156,000.00 | 1,581,000.00 |
| Profit Loss Before Tax | -61,084,000.00 | -27,579,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | -4,000.00 |
| Profit (loss) | -61,084,000.00 | -27,575,000.00 |
| Line item in (gbp) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | N/A | -61,084,000.00 | -27,575,000.00 |
| Cash Flows From Used In Operations | N/A | -7,294,000.00 | -6,221,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 0.00 | -4,000.00 |
| Cash Flows From Used In Operating Activities | N/A | -7,138,000.00 | -4,636,000.00 |
| Other Cash Receipts From Sales Of Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | N/A | 39,084,000.00 | 20,796,000.00 |
| Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | N/A | 59,221,000.00 | 33,623,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 101,000.00 | 8,000.00 |
| Cash Flows From Used In Investing Activities | N/A | 42,038,000.00 | -12,835,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 11,593,000.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 0.00 | 63,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -11,593,000.00 | -63,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 23,307,000.00 | -17,534,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -1,162,000.00 | 6,086,000.00 |
| Cash and cash equivalents | 112,085,000.00 | 134,230,000.00 | 122,782,000.00 |
Please note that some sums might not add up.
GB00BD045071
LEI213800OVT3AHQCXNIX43
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.